NCT06533995View on ClinicalTrials.gov

The Usefulness of Visuprime in Cataract Surgery

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

February 22, 2022

Study Completion Date

February 22, 2022

Conditions
Cataract
Interventions
DEVICE

Visuprime

Visuprime is a medical device (class IIa sterile) with ophtalmic indication, consisting on a 10 ml multidose bottle

OTHER

Placebo

placebo eyedrop isotonic buffered saline solution

Trial Locations (2)

00169

Policlinico Casilino, Rome

00171

Clinica Fabia Mater, Rome

All Listed Sponsors
lead

VISUfarma SpA

INDUSTRY

NCT06533995 - The Usefulness of Visuprime in Cataract Surgery | Biotech Hunter | Biotech Hunter